The Families At Risk for Interstitial Lung Disease Study
Sponsor: |
NIH |
Enrolling: |
Male and Female Patients |
Study Length: |
1 Days |
Clinic Visits: |
1 |
IRB Number: |
AAAR1916 |
U.S. Govt. ID: |
NCT03641742 |
Contact: |
M. Atif Choudhury: 212-342-4551 / mac2463@cumc.columbia.edu |
The Families At-Risk for Interstitial Lung Disease (FAR-ILD) study is designed to detect and study the earliest stages of ILD in adults with a family history of ILD. FAR-ILD is a non-interventional study. This means that FAR-ILD is not involved in testing any new interventions or therapies. The purpose of FAR-ILD is to gather data on family members of patients with pulmonary fibrosis over a long period of time in order to help physicians and investigators better understand interstitial lung disease. There is no cost associated with participating in FAR-ILD and your insurance will not be billed. All study procedures are paid for in full by the National Institutes of Health. If you enroll in the FAR-ILD study, you may be asked to undergo the following study-related procedures: CAT scan, pulmonary function testing, blood draw from a vein, bronchoscopy, & return visits.
This study is closed
Investigator
Christine Kim Garcia, MD
Do you or one of your family members have interstitial lung disease or pulmonary fibrosis? |
Yes |
No |